STRENSIQ

Google image searchProduct monograph

Active ingredient

asfotase alfa, 40 MG/ML

DIN: 02444623

Dosage form(s): SOLUTION

Route(s) of administration: SUBCUTANEOUS

Description: 28MG/0.7ML SINGLE USE VIAL

Schedule: Prescription / Schedule D

Company: ALEXION PHARMA GMBH

Date: 07-JUN-2016

ATC:

Reference brand drug: Strensiq

Search on Google